Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896

Watchlist Manager
Zhejiang Shouxiangu Pharmaceutical Co Ltd Logo
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Watchlist
Price: 21.37 CNY -0.6%
Market Cap: 4.2B CNY
Have any thoughts about
Zhejiang Shouxiangu Pharmaceutical Co Ltd?
Write Note

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Other Current Liabilities
ÂĄ14.1m
CAGR 3-Years
-21%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Other Current Liabilities
ÂĄ2.1B
CAGR 3-Years
57%
CAGR 5-Years
29%
CAGR 10-Years
26%
S
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
Other Current Liabilities
ÂĄ96m
CAGR 3-Years
-30%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Other Current Liabilities
ÂĄ475.8m
CAGR 3-Years
35%
CAGR 5-Years
21%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Other Current Liabilities
ÂĄ1.7B
CAGR 3-Years
3%
CAGR 5-Years
18%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Other Current Liabilities
ÂĄ230.7m
CAGR 3-Years
-51%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Consumer products

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the breeding, cultivation, processing, and sale of Chinese herbal pieces and health food. The company is headquartered in Jinhua, Zhejiang and currently employs 1,026 full-time employees. The company went IPO on 2017-05-10. The firm's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The firm mainly operates its businesses in domestic markets through wholesaling and direct sales.

Intrinsic Value
33.69 CNY
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Other Current Liabilities?
Other Current Liabilities
14.1m CNY

Based on the financial report for Sep 30, 2024, Zhejiang Shouxiangu Pharmaceutical Co Ltd's Other Current Liabilities amounts to 14.1m CNY.

What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-29%

Over the last year, the Other Current Liabilities growth was -39%. The average annual Other Current Liabilities growth rates for Zhejiang Shouxiangu Pharmaceutical Co Ltd have been -21% over the past three years , -29% over the past five years .

Back to Top